Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
17
First-line T-DXd showed promising activity signals in only HER2-altered NSCLC and, in EGFR-HER2 co-altered patients, the EGFR-TKI monotherapy showed limited efficacy.